Harmon Seth has filed 8 insider transactions across 1 company since March 2025.
Most recent transaction: a tax payment of 2031 shares of Viridian Therapeutics, Inc.\DE ($VRDN) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | F | Common Stock | 2031 | $30.19 | 7,850.0000 | 95,442,008 | 20.55% | 0.00% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | M | Restricted Stock Units | 6267 | $0.00 | 18,801.0000 | 95,442,008 | 25.00% | 0.01% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | A | Stock Option (Right to Buy) | 102850 | $0.00 | 102,850.0000 | 95,442,008 | 9999.99% | 0.11% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | A | Restricted Stock Units | 20550 | $0.00 | 20,550.0000 | 95,442,008 | 9999.99% | 0.02% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | F | Common Stock | 2091 | $29.32 | 7,790.0000 | 95,442,008 | 21.16% | 0.00% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | M | Common Stock | 6267 | $0.00 | 9,881.0000 | 95,442,008 | 173.41% | 0.01% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | A | Restricted Stock Units | 25068 | $0.00 | 25,068.0000 | 81,484,950 | 9999.99% | 0.03% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Harmon Seth | Chief Financial Officer | A | Stock Option (Right to Buy) | 150407 | $0.00 | 150,407.0000 | 81,484,950 | 9999.99% | 0.18% |